Glutamine metabolism in prostate cancer is also regulated by oncogenes like MYC, androgen receptors (AR), and mTOR, with metabolic tracing studies highlighting glutamine’s role in energy and precursor synthesis (234). The gene discussed is MTOR; the disease is prostate carcinoma.